NSTM — Novelstem International Balance Sheet
0.000.00%
- $0.38m
- $4.79m
- $0.01m
Annual balance sheet for Novelstem International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.09 | 0.009 | 0.006 | 0.053 | 0.006 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.012 | 0 | 0.011 |
Prepaid Expenses | |||||
Total Current Assets | 0.121 | 0.037 | 0.059 | 0.087 | 0.032 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 3.56 | 2.61 | 2.29 | 2.25 | 0.16 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.069 | 0.193 | 0.065 | 0.346 | 5.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.069 | 0.193 | 0.353 | 4.21 | 5.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 3.49 | 2.42 | 1.93 | -1.95 | -5.14 |
Total Liabilities & Shareholders' Equity | 3.56 | 2.61 | 2.29 | 2.25 | 0.16 |
Total Common Shares Outstanding |